Review





Similar Products

g igg level  (Valiant Co Ltd)
94
Valiant Co Ltd g igg level
G Igg Level, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/igm+and+igg+levels/pmc10290386__12944_2023_1826_MOESM1_ESM-17-8-18?v=Valiant+Co+Ltd
Average 94 stars, based on 1 article reviews
g igg level - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier
immunoglobulin g (igg), iga, and igm levels  (Merck KGaA)
90
Merck KGaA immunoglobulin g (igg), iga, and igm levels
Immunoglobulin G (Igg), Iga, And Igm Levels, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/igm+and+igg+levels/pm39940275-108-3-29?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
immunoglobulin g (igg), iga, and igm levels - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
igm levels  (Bethyl)
95
Bethyl igm levels
Igm Levels, supplied by Bethyl, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/igm+and+igg+levels/pm36155926-49-51-57?v=Bethyl
Average 95 stars, based on 1 article reviews
igm levels - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier
serum mp-igm and mp-igg level measured by clia  (Autobio Diagnostics)
90
Autobio Diagnostics serum mp-igm and mp-igg level measured by clia
Serum Mp Igm And Mp Igg Level Measured By Clia, supplied by Autobio Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/igm+and+igg+levels/pm36084539-67-11-15?v=Autobio+Diagnostics
Average 90 stars, based on 1 article reviews
serum mp-igm and mp-igg level measured by clia - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
whole-sars-cov-2 (crude extract virus) igg, igm and iga levels  (DIESSE Inc)
90
DIESSE Inc whole-sars-cov-2 (crude extract virus) igg, igm and iga levels
Whole Sars Cov 2 (Crude Extract Virus) Igg, Igm And Iga Levels, supplied by DIESSE Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/igm+and+igg+levels/pmc08684051-73-5-17?v=DIESSE+Inc
Average 90 stars, based on 1 article reviews
whole-sars-cov-2 (crude extract virus) igg, igm and iga levels - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
3 anti-sars-cov-2 antibody levels (anti-s1-igg, anti-s1-igm, and anti-n-igg)  (Sysmex Corporation)
90
Sysmex Corporation 3 anti-sars-cov-2 antibody levels (anti-s1-igg, anti-s1-igm, and anti-n-igg)
Correlations of neutralizing titers with injection-site pain scores and systemic fever grades. ( A ) No correlation was seen between NT 50 values and injection-site pain (Spearman’s ρ = 0.14; 95% CI 0.00–0.26, p = 0.043). The injection-site pain following the 2nd BNT162b2 dose was scored by using the short-form McGill Pain Questionnaire . ( B ) Correlation was negligible between NT 50 values and systemic fever grades (Spearman’s ρ = 0.26; 95% CI 0.13–0.38, p < 0.001). A solid-red circle indicates a person with previous <t>SARS-CoV-2</t> infection documented.
3 Anti Sars Cov 2 Antibody Levels (Anti S1 Igg, Anti S1 Igm, And Anti N Igg), supplied by Sysmex Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/igm+and+igg+levels/pmc08613264-163-3-39?v=Sysmex+Corporation
Average 90 stars, based on 1 article reviews
3 anti-sars-cov-2 antibody levels (anti-s1-igg, anti-s1-igm, and anti-n-igg) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
immunoglobulin levels (igg, iga, and igm) assayed by nephelometry siemens bn2 nephelometer  (Siemens AG)
90
Siemens AG immunoglobulin levels (igg, iga, and igm) assayed by nephelometry siemens bn2 nephelometer
Correlations of neutralizing titers with injection-site pain scores and systemic fever grades. ( A ) No correlation was seen between NT 50 values and injection-site pain (Spearman’s ρ = 0.14; 95% CI 0.00–0.26, p = 0.043). The injection-site pain following the 2nd BNT162b2 dose was scored by using the short-form McGill Pain Questionnaire . ( B ) Correlation was negligible between NT 50 values and systemic fever grades (Spearman’s ρ = 0.26; 95% CI 0.13–0.38, p < 0.001). A solid-red circle indicates a person with previous <t>SARS-CoV-2</t> infection documented.
Immunoglobulin Levels (Igg, Iga, And Igm) Assayed By Nephelometry Siemens Bn2 Nephelometer, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/igm+and+igg+levels/pmc08221090-40-9-10?v=Siemens+AG
Average 90 stars, based on 1 article reviews
immunoglobulin levels (igg, iga, and igm) assayed by nephelometry siemens bn2 nephelometer - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
anti-sars-cov-2 igm and igg levels using qualitative lateral flow immunochromatographic assay (ica)  (SD Biosensor)
90
SD Biosensor anti-sars-cov-2 igm and igg levels using qualitative lateral flow immunochromatographic assay (ica)
Correlations of neutralizing titers with injection-site pain scores and systemic fever grades. ( A ) No correlation was seen between NT 50 values and injection-site pain (Spearman’s ρ = 0.14; 95% CI 0.00–0.26, p = 0.043). The injection-site pain following the 2nd BNT162b2 dose was scored by using the short-form McGill Pain Questionnaire . ( B ) Correlation was negligible between NT 50 values and systemic fever grades (Spearman’s ρ = 0.26; 95% CI 0.13–0.38, p < 0.001). A solid-red circle indicates a person with previous <t>SARS-CoV-2</t> infection documented.
Anti Sars Cov 2 Igm And Igg Levels Using Qualitative Lateral Flow Immunochromatographic Assay (Ica), supplied by SD Biosensor, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/igm+and+igg+levels/pmc08108475-62-17-26?v=SD+Biosensor
Average 90 stars, based on 1 article reviews
anti-sars-cov-2 igm and igg levels using qualitative lateral flow immunochromatographic assay (ica) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
igg and igm rubella antibody titer levels  (Abbott Laboratories)
90
Abbott Laboratories igg and igm rubella antibody titer levels
Correlations of neutralizing titers with injection-site pain scores and systemic fever grades. ( A ) No correlation was seen between NT 50 values and injection-site pain (Spearman’s ρ = 0.14; 95% CI 0.00–0.26, p = 0.043). The injection-site pain following the 2nd BNT162b2 dose was scored by using the short-form McGill Pain Questionnaire . ( B ) Correlation was negligible between NT 50 values and systemic fever grades (Spearman’s ρ = 0.26; 95% CI 0.13–0.38, p < 0.001). A solid-red circle indicates a person with previous <t>SARS-CoV-2</t> infection documented.
Igg And Igm Rubella Antibody Titer Levels, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/igm+and+igg+levels/pmc07899702-81-7-24?v=Abbott+Laboratories
Average 90 stars, based on 1 article reviews
igg and igm rubella antibody titer levels - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Correlations of neutralizing titers with injection-site pain scores and systemic fever grades. ( A ) No correlation was seen between NT 50 values and injection-site pain (Spearman’s ρ = 0.14; 95% CI 0.00–0.26, p = 0.043). The injection-site pain following the 2nd BNT162b2 dose was scored by using the short-form McGill Pain Questionnaire . ( B ) Correlation was negligible between NT 50 values and systemic fever grades (Spearman’s ρ = 0.26; 95% CI 0.13–0.38, p < 0.001). A solid-red circle indicates a person with previous SARS-CoV-2 infection documented.

Journal: Scientific Reports

Article Title: Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals

doi: 10.1038/s41598-021-01930-y

Figure Lengend Snippet: Correlations of neutralizing titers with injection-site pain scores and systemic fever grades. ( A ) No correlation was seen between NT 50 values and injection-site pain (Spearman’s ρ = 0.14; 95% CI 0.00–0.26, p = 0.043). The injection-site pain following the 2nd BNT162b2 dose was scored by using the short-form McGill Pain Questionnaire . ( B ) Correlation was negligible between NT 50 values and systemic fever grades (Spearman’s ρ = 0.26; 95% CI 0.13–0.38, p < 0.001). A solid-red circle indicates a person with previous SARS-CoV-2 infection documented.

Article Snippet: Measurement of 3 anti-SARS-CoV-2 antibody levels (anti-S1-IgG, anti-S1-IgM, and anti-N-IgG) in sera of each participant obtained on days 7, 28, 60, 90, and 150 from 1st dose was performed using the chemiluminescence enzyme immunoassay (CLEIA) platform (HISCL) manufactured by Sysmex Co. (Kobe, Japan) as previously reported .

Techniques: Injection, Infection

Blockade of the infectivity and replication of SARS-CoV-2 variants by vaccinees’ sera on day 28 post-1st dose. The activity of vaccinees’ sera to block the infectivity and replication of 5 SARS-CoV-2 variants (alpha variants: SARS-CoV-2 QHN001 and SARS-CoV-2 QK002 ; a beta strain: SARS-CoV-2 TY8-612 ; a delta strain: SARS-CoV-2 1734 ; and a kappa strain: SARS-CoV-2 5356 ) was evaluated. A Wuhan strain SARS-CoV-2 05-2 N was employed as a reference SARS-CoV-2. Six sera were from elite responders (NT 50 > 1,500) and 12 sera were from randomly-selected moderate responders (NT 50 = 200 ~ 1,500). The NT 50 titers of each sera against 6 SARS-CoV-2 strains are shown in red circles (for 6 elite responders) and in black circles (for 12 moderate responders). D043 is a sera from a COVID-19-convalescent patient and served as an internal control in the assays. P values for the difference between the averages of elite and moderate responders in each variant: < 0.001 (05-2 N), 0.006 (QHN001), 0.004 (QK002), 0.035 (5356), 0.119 (1734), and 0.371(TY8).

Journal: Scientific Reports

Article Title: Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals

doi: 10.1038/s41598-021-01930-y

Figure Lengend Snippet: Blockade of the infectivity and replication of SARS-CoV-2 variants by vaccinees’ sera on day 28 post-1st dose. The activity of vaccinees’ sera to block the infectivity and replication of 5 SARS-CoV-2 variants (alpha variants: SARS-CoV-2 QHN001 and SARS-CoV-2 QK002 ; a beta strain: SARS-CoV-2 TY8-612 ; a delta strain: SARS-CoV-2 1734 ; and a kappa strain: SARS-CoV-2 5356 ) was evaluated. A Wuhan strain SARS-CoV-2 05-2 N was employed as a reference SARS-CoV-2. Six sera were from elite responders (NT 50 > 1,500) and 12 sera were from randomly-selected moderate responders (NT 50 = 200 ~ 1,500). The NT 50 titers of each sera against 6 SARS-CoV-2 strains are shown in red circles (for 6 elite responders) and in black circles (for 12 moderate responders). D043 is a sera from a COVID-19-convalescent patient and served as an internal control in the assays. P values for the difference between the averages of elite and moderate responders in each variant: < 0.001 (05-2 N), 0.006 (QHN001), 0.004 (QK002), 0.035 (5356), 0.119 (1734), and 0.371(TY8).

Article Snippet: Measurement of 3 anti-SARS-CoV-2 antibody levels (anti-S1-IgG, anti-S1-IgM, and anti-N-IgG) in sera of each participant obtained on days 7, 28, 60, 90, and 150 from 1st dose was performed using the chemiluminescence enzyme immunoassay (CLEIA) platform (HISCL) manufactured by Sysmex Co. (Kobe, Japan) as previously reported .

Techniques: Infection, Activity Assay, Blocking Assay, Variant Assay

Kinetics of neutralizing activity and S1-binding-IgG and -IgM levels. Time-course analyses of neutralizing activity for 90 days were conducted. The 1st vaccine was administered on day 0, and the 2nd vaccine on day 21. Blood samples from vaccinated individuals were obtained on days 7, 28, 60, 90 and 150 post 1st dose as illustrated in Table . ( A ) Neutralizing activity is shown as NT 50 (50% neutralizing titer). The NT 50 value of 20 is the detection limit and values determined to be less than 20 were treated as 20. ( B , C ) Kinetics of S1-binding-IgG and -IgM levels are shown. The average values of each data point are shown in black solid circles, which are connected with solid black lines. One participant, who had been infected with SARS-CoV-2 with PCR-positivity documented, is indicated as a solid-red solitary circle in ( B ) and ( C ). This participant was excluded from all analyses at later timepoints.

Journal: Scientific Reports

Article Title: Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals

doi: 10.1038/s41598-021-01930-y

Figure Lengend Snippet: Kinetics of neutralizing activity and S1-binding-IgG and -IgM levels. Time-course analyses of neutralizing activity for 90 days were conducted. The 1st vaccine was administered on day 0, and the 2nd vaccine on day 21. Blood samples from vaccinated individuals were obtained on days 7, 28, 60, 90 and 150 post 1st dose as illustrated in Table . ( A ) Neutralizing activity is shown as NT 50 (50% neutralizing titer). The NT 50 value of 20 is the detection limit and values determined to be less than 20 were treated as 20. ( B , C ) Kinetics of S1-binding-IgG and -IgM levels are shown. The average values of each data point are shown in black solid circles, which are connected with solid black lines. One participant, who had been infected with SARS-CoV-2 with PCR-positivity documented, is indicated as a solid-red solitary circle in ( B ) and ( C ). This participant was excluded from all analyses at later timepoints.

Article Snippet: Measurement of 3 anti-SARS-CoV-2 antibody levels (anti-S1-IgG, anti-S1-IgM, and anti-N-IgG) in sera of each participant obtained on days 7, 28, 60, 90, and 150 from 1st dose was performed using the chemiluminescence enzyme immunoassay (CLEIA) platform (HISCL) manufactured by Sysmex Co. (Kobe, Japan) as previously reported .

Techniques: Activity Assay, Binding Assay, Infection